Table 2.
Physical health | NMPOU, n (%)
|
Abuse/Dep, n (%)
|
OR (95% Cl)
|
AOR1 (95% Cl)
|
AOR2 (95% Cl)
|
|||||
---|---|---|---|---|---|---|---|---|---|---|
No | Yes | No | Yes | NMPOU | Abuse/Dep | NMPOU | Abuse/Dep | NMPOU | Abuse/Dep | |
Number of physical health conditions (0–9) | – | – | – | – | 0.93(0.82–1.04) | 1.14(0.97–1.35) | 1.19(1.07–1.32)** | 1.62(1.42–1.84)*** | 1.12(1.00–1.25) | 1.42(1.23–1.63)*** |
Arteriosclerosis or hypertension | 479(1.93) | 92(1.33) | 150(0.61) | 33(0.66) | 0.69(0.51–0.92)** | 1.08(0.64–1.84) | 1.15(0.82–1.60) | 2.53(1.50–4.28)*** | 1.05(0.75–1.46) | 2.02(1.18–3.46)** |
Hepatic disease | 565(1.81) | 6(2.44) | 181(0.61) | 3(2.90) | 1.36(0.49–3.77) | – | 1.60(0.58–4.42) | – | 1.30(0.48–3.54) | – |
Cardiovascular disease | 520(l.79) | 51(2.15) | 162(0.59) | 20(1.06) | 1.21(0.82–1.78) | 1.81(0.89–3.71) | 1.80(1.22–2.66)** | 3.20(1.49–6.87)** | 1.53(1.02–2.28)* | 2.22(1.01–4.89)* |
Gastrointestinal disease | 526(1.78) | 44(2.20) | 166(0.61) | 18(0.88) | 1.24(0.84–1.83) | 1.44(0.78–2.65) | 1.58(1.06–2.36)* | 1.98(1.08–3.60)* | 1.33(0.89–1.98) | 1.36(0.75–2.44) |
Arthritis | 482(1.86) | 92(1.61) | 146(0.60) | 37 (0.70) | 0.86(0.65–1.15) | 1.18(0.73–1.91) | 1.49(1.09–2.03)** | 2.71(1.51–4.85)*** | 1.34(0.99–1.82) | 2.09(1.20–3.63)** |
Any assessed medical condition | 388(1.92) | 183(1.61) | 112(0.54) | 70(0.77) | 0.84(0.67–1.05) | 1.42(0.94–2.16) | 1.44(1.12–1.85)** | 3.38(2.25–5.07)*** | 1.25(0.97–1.61) | 2.47(1.66–3.67)*** |
OR, odds ratio; AOR1, adjusted for sex, age, marital status, education, household income, race; AOR2, adjusted for sociodemographic factors and Axis I and II mental disorders. For prevalence rates, yes = percentage of individuals with the physical condition who have NMPOU or abuse/dependence, respectively; no = percentage of individuals without the physical condition who have NMPOU or abuse/dependence, respectively. NMPOU, non-medical prescription opioid use; abuse/dep, opioid abuse and/or dependence.
p ≤ 0.05.
p ≤ 0.01.
p ≤ 0.001.